Polycythemia Vera Therapies
Apr 10, 2026
5 Emerging Polycythemia Vera Therapies Eyeing Market Dominance
Summary Three drugs that have been approved for PV include JAKAFI/JAKAVI (ruxolitinib), BESREMi (ropeginterferon alfa-2B/AOP2014/P1101), and PEGASYS (peginterferon alfa-2a). JAKAFI and BESREMi are approved in the US, Europe, and Japan, while PEGASYS is approved only in Europe. JAKAFI is nearing its pat...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
